GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Clinical trials for GPC3 POSITIVE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GPC3 POSITIVE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for GPC3 POSITIVE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on advanced liver cancer
Disease control Recruiting nowThis early-phase trial is testing a new treatment called Super CAR-T for people with advanced hepatocellular carcinoma, a type of liver cancer that has spread. The treatment involves taking a patient's own immune cells, modifying them to better recognize and attack cancer cells, …
Matched conditions: GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New cell therapy trial targets hard-to-treat solid tumors
Disease control Recruiting nowThis early-phase trial tests a new treatment called TC-G203 for people with GPC3-positive solid tumors that have come back or spread after other treatments. The main goal is to find the safest dose and see if the therapy can shrink tumors. About 30 adults aged 18-75 who have not …
Matched conditions: GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC